botMB to Hacker News · 1 month agoTrial results for new lung cancer drug are 'off the charts'www.theguardian.comexternal-linkmessage-square3fedilinkarrow-up115arrow-down10file-text
arrow-up115arrow-down1external-linkTrial results for new lung cancer drug are 'off the charts'www.theguardian.combotMB to Hacker News · 1 month agomessage-square3fedilinkfile-text
minus-squarewill_a113@lemmy.mllinkfedilinkarrow-up3·1 month agoNew drug: 60% survival rate with no disease progression. Current-best drug: 8% While technically it’s not “off the charts”, this is pretty damn impressive. I’ll allow the hyperbole.
New drug: 60% survival rate with no disease progression.
Current-best drug: 8%
While technically it’s not “off the charts”, this is pretty damn impressive. I’ll allow the hyperbole.